BackIronwood Pharmaceuticals Overview
Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A

Ironwood Pharmaceuticals Discounted Cash Flow

DCF Analysis for IRWD.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$11.57

Current Fair Value

$11.57
226.9% Upside

Undervalued by 226.9% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading